Published in Am J Dis Child on May 01, 1984
Epidemiology of chickenpox in England and Wales, 1967-85. Br Med J (Clin Res Ed) (1988) 2.07
Nosocomial spread of viral disease. Clin Microbiol Rev (2001) 1.05
Varicella vaccination in Europe: are we ready for a universal childhood programme? Eur J Pediatr (2007) 0.96
Errant processing and structural alterations of genomes present in a varicella-zoster virus vaccine. J Virol (1985) 0.88
Health care budgets and vaccine programs: a time for review and prioritization. CMAJ (1994) 0.86
Immunological aspects of the prevention of viral diseases. WHO Workshop. Bull World Health Organ (1987) 0.75
Ampicillin-resistant Haemophilus influenzae type B infection. JAMA (1974) 5.90
Field Evaluation of a Human Anthrax Vaccine. Am J Public Health Nations Health (1962) 5.44
The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer (2000) 4.89
Generation in vitro of deletions in the broad host range plasmid RK2 using phage Mu insertions and a restriction endonuclease. Gene (1976) 4.35
Micromethod system for identification of anaerobic bacteria. Appl Microbiol (1973) 4.18
Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med (1992) 4.02
Mortality rates in displaced and resident populations of central Somalia during 1992 famine. Lancet (1993) 3.84
Measles antibody: reevaluation of protective titers. J Infect Dis (1990) 3.77
Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med (1994) 3.61
Rational strategy for rubella vaccination. Lancet (1983) 3.61
Cytopathic effect of rubella virus in RHK21 cells and growth to high titers in suspension culture. Virology (1965) 3.50
Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst (1999) 3.19
Changing patterns in epidemiology of Crohn's disease. Lancet (1974) 2.99
Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med (1994) 2.82
Trends in self-reported use of mammograms (1989-1997) and Papanicolaou tests (1991-1997)--Behavioral Risk Factor Surveillance System. MMWR CDC Surveill Summ (1999) 2.77
Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med (1992) 2.71
Varicella vaccine for healthy children. Lancet (1994) 2.64
Detection of cell-dependent cytotoxic antibody to cells infected with herpes simplex virus. Nature (1974) 2.55
Attitudes toward clinical trials among patients and the public. JAMA (1982) 2.53
Cancer incidence and mortality, 1973-1995: a report card for the U.S. Cancer (1998) 2.48
Comparison of three anaerobic systems for the isolation of anaerobic bacteria from clinical specimens. Am J Clin Pathol (1973) 2.47
Actinomycin D: inhibition of respiration and glycolysis. Science (1966) 2.47
Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial. Ann Intern Med (1991) 2.42
Human cytomegalovirus stimulates host cell RNA synthesis. J Virol (1975) 2.41
Patterns of transmission in measles outbreaks in the United States, 1985-1986. N Engl J Med (1989) 2.41
A simple method for removal of rubella hemagglutination inhibitors from serum adaptable to finger-tip blood. Am J Epidemiol (1968) 2.36
Cytomegalovirus replicates in differentiated but not in undifferentiated human embryonal carcinoma cells. Science (1984) 2.34
Psychosocial status in chronic illness. A comparative analysis of six diagnostic groups. N Engl J Med (1984) 2.24
The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women. AJR Am J Roentgenol (1998) 2.24
Demonstration of immunoglobulin G receptors induced by human cytomegalovirus. J Clin Microbiol (1975) 2.21
Human monocyte-macrophage-mediated antibody-dependent cytotoxicity to herpes simplex virus-infected cells. J Immunol (1977) 2.21
A persistent outbreak of measles despite appropriate prevention and control measures. Am J Epidemiol (1987) 2.13
Congenital rubella syndrome in the United States, 1970-1985. On the verge of elimination. Am J Epidemiol (1989) 2.12
After the hospital episode. Lancet (1975) 2.11
Response of mice to rotaviruses of bovine or primate origin assessed by radioimmunoassay, radioimmunoprecipitation, and plaque reduction neutralization. Infect Immun (1983) 2.06
Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus. Ann Intern Med (1984) 2.01
Candidate cytomegalovirus strain for human vaccination. Infect Immun (1975) 1.99
Knowledge, attitudes, and screening practices among older men regarding prostate cancer. Am J Public Health (2000) 1.99
Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J Virol (2001) 1.98
Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis (1988) 1.97
Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. J Infect Dis (1995) 1.92
A murine model for oral infection with a primate rotavirus (simian SA11). J Virol (1984) 1.91
From the Center for Disease control: current status of measles in the United States, 1973--1977. J Infect Dis (1978) 1.91
Minimal infective dose of attenuated poliovirus for man. Am J Public Health Nations Health (1967) 1.89
Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge. J Infect Dis (1989) 1.89
Septin: a factor in plasma that opsonizes lipopolysaccharide-bearing particles for recognition by CD14 on phagocytes. J Exp Med (1992) 1.85
Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants. Lancet (1984) 1.81
Expression of the gene defect in X-linked agammaglobulinemia. N Engl J Med (1986) 1.80
Appropriate age for measles vaccination in the United States. Dev Biol Stand (1986) 1.80
Enhancement of vaginal infection in mice by herpes simplex virus type II with progesterone. Proc Soc Exp Biol Med (1978) 1.78
The cultivation of human rotavirus, strain 'Wa', to high titer in cell culture and characterization of the viral structural polypeptides. J Virol Methods (1983) 1.76
Age-specific risks of varicella complications. Pediatrics (1981) 1.76
Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States. JAMA (1973) 1.73
Human polymorphonuclear leucocytes as mediators of antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells. Clin Exp Immunol (1977) 1.73
Current status of mumps and mumps vaccine in the United States. Pediatrics (1978) 1.71
Congenital rubella syndrome as a systemic infection. Studies of affected infants born in Philadelphia, U.S.A. Br Med J (1965) 1.70
Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J (1990) 1.70
The measurement of food and energy intake in man-an evaluation of some techniques. Am J Clin Nutr (1980) 1.68
Role of T lymphocytes in recovery from murine cytomegalovirus infection. Infect Immun (1977) 1.68
Clinical trials of immunization with the Towne 125 strain of human cytomegalovirus. J Infect Dis (1976) 1.68
Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 1.67
Stimulation of macromolecular synethesis in guinea pig cells by human CMV. Proc Soc Exp Biol Med (1975) 1.67
Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis (1996) 1.66
The Rand Health Insurance Study: a summary critique. Med Care (1987) 1.65
Ampicillin-resistant, beta-lactamase-negative haemophilus influenzae type b. Pediatrics (1982) 1.64
Incidence of Lyme borreliosis in the Würzburg region of Germany. Eur J Clin Microbiol Infect Dis (1999) 1.64
Human cell culture rabies vaccine. Antibody response in man. JAMA (1973) 1.63
Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts. J Exp Med (1986) 1.63
Epidemiology of pertussis, Atlanta, 1977. J Pediatr (1981) 1.62
Human leukemia cell antigens: serologic characterization with xenoantisera. J Natl Cancer Inst (1974) 1.60
Measles outbreak among unvaccinated preschool-aged children: opportunities missed by health care providers to administer measles vaccine. Pediatrics (1989) 1.57
Gluttony. 1. An experimental study of overeating low- or high-protein diets. Am J Clin Nutr (1967) 1.57
Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine (1991) 1.57
Nonproductive infection of guinea pig cells with human cytomegalovirus. J Virol (1973) 1.56
Oral poliovirus vaccination in newborn African infants. The inhibitory effect of breast feeding. Am J Dis Child (1966) 1.56
A new attenuated rubella virus grown in human fibroblasts: evidence for reduced nasopharyngeal excretion. Am J Epidemiol (1967) 1.56
Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks. Virology (1996) 1.55
The demographic and social characteristics of patients with Crohn's disease in the Nottingham area. Scand J Gastroenterol (1976) 1.54
Rubella vaccination in the United States: a ten-year review. Epidemiol Rev (1980) 1.53
Lamivudine therapy of WHV-infected woodchucks. Virology (1998) 1.52
Interactions of HIV protease inhibitors with ATP-dependent drug export proteins. Mol Pharmacol (1999) 1.52
Fetal risk associated with rubella vaccine: an update. Rev Infect Dis (1985) 1.50
Abnormalities of fragile histidine triad genomic and complementary DNAs in cervical cancer: association with human papillomavirus type. J Natl Cancer Inst (1998) 1.50
Routine quantitative blood cultures in children with Haemophilus influenzae or Streptococcus pneumoniae bacteremia. Pediatrics (1985) 1.50
Adenovirus-based p53 gene therapy in ovarian cancer. Gynecol Oncol (1995) 1.49
Psychosocial correlates of survival in advanced malignant disease? N Engl J Med (1985) 1.48
Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic. Mol Pharmacol (2001) 1.48
Clinical importance of n-3 fatty acid-rich diet and nutritional education for the maintenance of remission in Crohn's disease. J Gastroenterol (2000) 1.47
Mechanisms mediating renal secretion of organic anions and cations. Physiol Rev (1993) 1.45
Outbreak of cryptosporidiosis in a day-care center. Pediatrics (1986) 1.44
The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants. J Infect Dis (1996) 1.42
Responding to The River. Science (1999) 1.42
Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers. Am J Clin Nutr (1989) 1.42
Varicella: complications and costs. Pediatrics (1986) 1.41
Epidemiology of rotavirus electropherotypes determined by a simplified diagnostic technique with RNA analysis. J Clin Microbiol (1985) 1.40
Human parvovirus B19 infection among hospital staff members after contact with infected patients. N Engl J Med (1989) 1.40